Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

NCT04372186 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT04372186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04372186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia
Lead sponsor
Genentech, Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 14, 2020
Completion date
September 22, 2020
Enrollment
377 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia